AstraZeneca completes $39bn acquisition of Alexion Pharmaceuticals
With the acquisition, AstraZeneca now has an enhanced presence in rare diseases and immunology fields, using Alexion’s complement-biology…
Lilly acquires Protomer Technologies in $1bn deal
15 Jul 21In a previous equity investment round, Lilly acquired a 14% stake in California-based Promoter
Sanofi to sell eight consumer healthcare brands in Latin America to Hypera Pharma
14 Jul 21The sale is part of Sanofi’s strategy to simplify its consumer healthcare portfolio and advance its growth
Novo Nordisk to buy Prothena’s ATTR amyloidosis business
13 Jul 21Novo Nordisk intends to initially develop the Phase 2 ready antibody PRX004 for the rare heart disease ATTR…
Biogen collaborates with Innocare for potential MS drug orelabrutinib
13 Jul 21InnoCare is expected to receive a $125m upfront payment in addition to potential milestone payments and tiered royalties
Philip Morris to buy inhaled therapeutics firm Vectura for £852m
12 Jul 21With the acquisition, PMI will get access to technology and pharmaceutical development expertise to deliver complex inhaled therapies
Perrigo closes sale of Generic Rx business for $1.55bn
07 Jul 21With the divestiture of Generic Rx Pharmaceutical business, Perrigo will become a pure-play global consumer self-care company
Philip Morris to acquire Fertin Pharma in $820m deal
02 Jul 21The acquisition of Fertin Pharma would support PMI’s goal of generating more than 50% revenues from smoke-free products…
Danaher to acquire biologics manufacturer Aldevron for $9.6bn
18 Jun 21Upon closing of the transaction, Aldevron will operate as an individual company and a brand operating within Danaher's…
Exscientia acquires precision medicine company Allcyte for €50m
17 Jun 21Allcyte’s platform anticipates the activity of cancer treatments using AI to analyse the activity of drugs in live…